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Clinics and pathology 
Disease 
Anaplastic lymphoma kinase (ALK) -positive diffuse 
large B-cell lymphoma (DLBCL) is a variant of 
DLBCL, expressing the ALK kinase (Delsol et al., 
2008). 
Phenotype/cell stem origin 
The postulated normal counterpart is post-germinal 
centre B cell with features of plasma cell 
differentiation.  
The immunophenotype typically show ALK+ 
(cytoplasmic staining). Plasma cell markers such as 
CD138 test positive, whereas B-cell markers such as 
CD20 and CD79a are negative, CD30 is usually 
negative. Cytoplasmic staining for IgA and, less 
frequently, IgG is typically seen in the majority of
cases. 
Clinics 
The disease runs an aggressive course (Laurent et al., 
2010). Long term survival was reported in some 
children. 
Pathology 
The lymph node sections show large immunoblastic 
cells with nucleoli. 
Treatment 
Chemotherapy using CHOP or CHOP-like regimens is 
the standard of care. Due to CD20 negativity, the 
monoclonal antibody rituximab is ineffective. 
Prognosis 
Median overall survival was 20 months in a study 




The Ig gene is clonally rearranged. 
The founder lesion involves the ALK gene on 
chromosome 2 (Lee et al., 2008).  
The t(2;17)(p23;q23) determining the clathrin/ALK 
fusion is the most frequent aberration (Chikatsu et al., 
2003), accounting for approximately 70% of the cases. 
The classical t(2;5)(p23;q35) was reported in 10% of 
the cases (Adam et al., 2003). 
Other aberrations, mostly reported in individual cases 
include: 
- cryptic insertion of the ALK gene into chromosome 
4q22 (Stachurski et al., 2007), 
- cryptic SEC31A-ALK fusion generated by an 
insertion of the 5' end of SEC31A (4q21) upstream of 
the 3' end of ALK. An in-frame fusion transcript in
which exon 24 of SEC31A (4q21) was fused to exon 20 
of ALK is generated by this rearrangement (Van 
Roosbroeck et al., 2010). 
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